Carbon ion radiotherapy for bone and soft tissue sarcomas

T. Kamada, S. Sugahara, R. Imai, M. Suzuki, T. Okada, H. Tsuji & H. Tsujii
A dose escalation trial (phase I/II trial) with a total dose ranging from 52.8 GyE to 73.6 GyE administered in 16 fractions over four weeks (with a single radiation dose of 3.3–4.6 GyE) was carried out on 64 lesions of 57 bone and soft tissue sarcoma patients during the period from June [for full text, please go to the a.m. URL]